Progenics Pharmaceuticals, Inc. (PGNX) said Wednesday that it is offering to sell shares of its common stock pursuant to an effective registration statement in an underwritten public offering.
Progenics also plans to grant the underwriter a 30-day option to purchase additional shares of common stock.
All of the shares to be sold in the offering are to be sold by Progenics, with the proceeds to be used for research and development and general corporate purposes.
Jefferies & Company, Inc. is acting as sole book-running manager for the proposed offering.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.